Search results
Study reveals how COVID-19 vaccines prevent severe disease
Medical Xpress· 3 days agoEmploying contemporary "big-data" analyses, scientists can find novel associations between fundamental biological entities and indicators of the severity of a disease—to build patterns of health ...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 5 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
Global survey shows COVID booster uptake in question
Center for Infectious Disease Research and Policy· 6 days agoThe 23 countries included were Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 2 hours agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost ...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 3 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 5 days agoIt would produce half a billion doses of its Covid-19 vaccine annually, it said. “This is major,”...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 4 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called ...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 5 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 2 hours agoIn pre-market activity on the Nasdaq, BioNTech shares were trading at $88.05, down 5.04 percent. The year-over-year change was mainly due to lower commercial revenues from the sales of BioNTech's ...
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters via Yahoo Finance· 28 minutes agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest...